The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
EFFECT OF CYP3A5 POLYMORPHISM ON TACROLIMUS METABOLIC CLEARANCE IN VITRO
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic Renal Failure after Transplantation of a Nonrenal Organ
Ojo, A. O., Held, P. J., Port, F. K., Wolfe, R. A., Leichtman, A. B., Young, E. W., Arndorfer, J., Christensen, L., & Merion, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021744 · Cited by 2,220
Kuehl, P., Zhang, J., Lin, Y., Lamba, J., Assem, M., Schuetz, J., Watkins, P. B., Daly, A., Wrighton, S. A., Hall, S. D., et al. (2001) · Nature Genetics · doi:10.1038/86882 · Cited by 2,162
Self-citationGenetic contribution to variable human CYP3A-mediated metabolism
Lamba, J. K., Lin, Y. S., Schuetz, E. G., & Thummel, K. E. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00066-2 · Cited by 990
Self-citationPaine, M. F., Khalighi, M., Fisher, J. M., Shen, D. D., Kunze, K. L., Marsh, C. L., Perkins, J. D., & Thummel, K. E. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37149-6 · Cited by 789
Self-citationHesselink, D. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00168-1 · Cited by 655
Korzekwa, K. R., Krishnamachary, N., Shou, M., Ogai, A., Parise, R. A., Rettie, A. E., Gonzalez, F. J., & Tracy, T. S. (1998) · Biochemistry · doi:10.1021/bi9715627 · Cited by 511
Aoyama, T., Yamano, S., Waxman, D. J., Lapenson, D. P., Meyer, U. A., Fischer, V, Tyndale, R., Inaba, T., Kalow, W., Gelboin, H. V., et al. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81632-5 · Cited by 482
Co-Regulation of CYP3A4 and CYP3A5 and Contribution to Hepatic and Intestinal Midazolam Metabolism
Lin, Y. S., Dowling, A. L. S., Quigley, S. D., Farin, F. M., Zhang, J., Lamba, J., Schuetz, E. G., & Thummel, K. E. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.162 · Cited by 449
Self-citationHaufroid, V., Mourad, M., Van Kerckhove, V., Wawrzyniak, J., De Meyer, M., Eddour, D. C., Malaise, J., Lison, D., Squifflet, J.-P., & Wallemacq, P. (2004) · Pharmacogenetics · doi:10.1097/00008571-200403000-00002 · Cited by 447
Tacrolimus: A Further Update of its Use in the Management of Organ Transplantation
Scott, L. J., McKeage, K., Keam, S. J., & Plosker, G. L. (2003) · Drugs · doi:10.2165/00003495-200363120-00006 · Cited by 422
Sattler, M., Guengerich, F. P., Yun, C. H., Christians, U., & Sewing, K. F. (1992) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08793-8 · Cited by 385
(2001) · PubMed · Cited by 316
Lampen, A., Christians, U., Guengerich, F. P., Watkins, P. B., Kolars, J. C., Bader, A., Gonschior, A. K., Dralle, H., Hackbarth, I., & Sewing, K. F. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06862-x · Cited by 273
Consensus Document: Therapeutic Monitoring of Tacrolimus (FK-506)
Jusko, W. J., Thomson, A. W., Fung, J. J., McMaster, P. D., Wong, S. H., Zylber‐Katz, E., Christians, U., Winkler, M., Fitzsimmons, W. E., Lieberman, R., et al. (1995) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199512000-00011 · Cited by 267
Pharmacokinetics of tacrolimus in liver transplant patients*
Jusko, W. J., Piekoszewski, W., Klintmalm, G. B., Shaefer, M. S., Hebert, M. F., Piergies, A. A., Lee, C. C., Schechter, P., & Mekki, Q. A. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90153-1 · Cited by 249
Self-citationContribution of CYP3A5 to the in Vitro Hepatic Clearance of Tacrolimus
Kamdem, L. K., Streit, F., Zanger, U. M., Brockmöller, J., Oellerich, M., Armstrong, V. W., & Wojnowski, L. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.050047 · Cited by 218
The pharmacokinetics and metabolic disposition of tacrolimus: A comparison across ethnic groups
Mancinelli, L. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113183 · Cited by 206
Obach, R. S., & Reed-Hagen, A. E. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.7.831 · Cited by 185
EVIDENCE OF SIGNIFICANT CONTRIBUTION FROM CYP3A5 TO HEPATIC DRUG METABOLISM
Huang, W., Lin, Y. S., McConn, D. J., Calamia, J. C., Totah, R. A., Isoherranen, N., Glodowski, M., & Thummel, K. E. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001313 · Cited by 175
Self-citationMöller, A., Iwasaki, K., Kawamura, A., Teramura, Y., Shiraga, T., Hata, T., Schäfer, A., & Undre, N. A. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15298-1 · Cited by 165
In vitro metabolism of cyclosporine A by human kidney CYP3A5
Dai, Y., Iwanaga, K., Lin, Y. S., Hébert, M. F., Davis, C. L., Huang, W., Kharasch, E. D., & Thummel, K. E. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.012 · Cited by 133
Self-citationCYP3A5genotype predicts renal CYP3A activity and blood pressure in healthy adults
Givens, R. C., Lin, Y. S., Dowling, A. L. S., et al. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00322.2003 · Cited by 132
Shiraga, T., MATSUDA, H., Nagase, K., Iwasaki, K., Kosei, N. O. D. A., Yamazaki, H., Shimada, T., & Funae, Y. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90136-8 · Cited by 127
Iwasaki, K., Shiraga, T., Nagase, K., Tozuka, Z., Kosei, N. O. D. A., Sakuma, S., FUJITSU, T., Shimatani, K., Sato, A., & Fujioka, M. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08219-4 · Cited by 106
Hortelano, S., Castilla, M., Torres, A. M., Tejedor, A., & Boscá, L. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11122315 · Cited by 92
Cytochrome P450 CYP3A in human renal cell cancer
Murray, G. I., McFadyen, M. C. E., Mitchell, R. T., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690292 · Cited by 85
Cited by
Calcineurin Inhibitor Nephrotoxicity
Naesens, M., Kuypers, D. R. J., & Sarwal, M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04800908 · Cited by 1,489
Inhibition and induction of human cytochrome P450 enzymes: current status
Pelkonen, O., Turpeinen, M., Hakkola, J., Honkakoski, P., Hukkanen, J., & Raunio, H. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0332-8 · Cited by 569
Staatz, C. E., Goodman, L. K., & Tett, S. E. (2010) · Clinical Pharmacokinetics · doi:10.2165/11317550-000000000-00000 · Cited by 343
Bièche, I., Narjoz, C., Asselah, T., Vacher, S., Marcellin, P., Lidereau, R., Beaune, P., & de Waziers, I. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32810f2e58 · Cited by 341
Staatz, C. E., Goodman, L. K., & Tett, S. E. (2010) · Clinical Pharmacokinetics · doi:10.2165/11317350-000000000-00000 · Cited by 336
Metadata
- Authors
- Dai, Y., Hebert, M. F., Isoherranen, N., Davis, C. L., Marsh, C., Shen, D. D., & Thummel, K. E.
- Venue
- Drug Metabolism and Disposition
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 34
- Issue
- 5
- Pages
- 836-847
- ISSN
- 0090-9556 (ISSN-L)
- OpenAlex
- W2099937170
- Cited by
- 279
- References
- 26
- FWCI
- 8.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.